Donate Help Contact The AHA Sign In Home
American Heart Association
Circulation
Search: search_blue_button Advanced Search
Circulation. 1989;79:8-15

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Gordon, D. J.
Right arrow Articles by Tyroler, H. A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Gordon, D. J.
Right arrow Articles by Tyroler, H. A.

Circulation, Vol 79, 8-15, Copyright © 1989 by American Heart Association


ARTICLES

High-density lipoprotein cholesterol and cardiovascular disease. Four prospective American studies

DJ Gordon, JL Probstfield, RJ Garrison, JD Neaton, WP Castelli, JD Knoke, DR Jacobs Jr, S Bangdiwala and HA Tyroler
Lipid Metabolism-Atherogenesis Branch, National Institutes of Health, Bethesda, Maryland, MD 20892.

The British Regional Heart Study (BRHS) reported in 1986 that much of the inverse relation of high-density lipoprotein cholesterol (HDLC) and incidence of coronary heart disease was eliminated by covariance adjustment. Using the proportional hazards model and adjusting for age, blood pressure, smoking, body mass index, and low-density lipoprotein cholesterol, we analyzed this relation separately in the Framingham Heart Study (FHS), Lipid Research Clinics Prevalence Mortality Follow- up Study (LRCF) and Coronary Primary Prevention Trial (CPPT), and Multiple Risk Factor Intervention Trial (MRFIT). In CPPT and MRFIT (both randomized trials in middle-age high-risk men), only the control groups were analyzed. A 1-mg/dl (0.026 mM) increment in HDLC was associated with a significant coronary heart disease risk decrement of 2% in men (FHS, CPPT, and MRFIT) and 3% in women (FHS). In LRCF, where only fatal outcomes were documented, a 1-mg/dl increment in HDLC was associated with significant 3.7% (men) and 4.7% (women) decrements in cardiovascular disease mortality rates. The 95% confidence intervals for these decrements in coronary heart and cardiovascular disease risk in the four studies overlapped considerably, and all contained the range 1.9-2.9%. HDLC levels were essentially unrelated to non- cardiovascular disease mortality. When differences in analytic methodology were eliminated, a consistent inverse relation of HDLC levels and coronary heart disease event rates was apparent in BRHS as well as in the four American studies.


This article has been cited by other articles:


Home page
HeartHome page
S. Wild and C. D Byrne
Time to rethink high-density lipoprotein?
Heart, June 1, 2008; 94(6): 692 - 694.
[Full Text] [PDF]


Home page
HeartHome page
D J Hausenloy and D M Yellon
Targeting residual cardiovascular risk: raising high-density lipoprotein cholesterol levels
Heart, June 1, 2008; 94(6): 706 - 714.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
M. Davidson, P. M. Meyer, S. Haffner, S. Feinstein, R. D'Agostino Sr, G. T. Kondos, A. Perez, Z. Chen, and T. Mazzone
Increased High-Density Lipoprotein Cholesterol Predicts the Pioglitazone-Mediated Reduction of Carotid Intima-Media Thickness Progression in Patients With Type 2 Diabetes Mellitus
Circulation, April 22, 2008; 117(16): 2123 - 2130.
[Abstract] [Full Text] [PDF]


Home page
J. Nutr.Home page
A. E. Griel, Y. Cao, D. D. Bagshaw, A. M. Cifelli, B. Holub, and P. M. Kris-Etherton
A Macadamia Nut-Rich Diet Reduces Total and LDL-Cholesterol in Mildly Hypercholesterolemic Men and Women
J. Nutr., April 1, 2008; 138(4): 761 - 767.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
S. D. Anderson and A. B. Salgado
Letter Regarding Article by Leeper et al, "Statin Use in Patients With Extremely Low Low-Density Lipoprotein Levels Is Associated With Improved Survival"
Circulation, March 4, 2008; 117(9): e174 - e174.
[Full Text] [PDF]


Home page
Eur Heart JHome page
V. Stangl, V. Witzel, G. Baumann, and K. Stangl
Current diagnostic concepts to detect coronary artery disease in women
Eur. Heart J., March 2, 2008; 29(6): 707 - 717.
[Abstract] [Full Text] [PDF]


Home page
Ann Clin BiochemHome page
G. Ferns and V. Keti
HDL-cholesterol modulation and its impact on the management of cardiovascular risk
Ann Clin Biochem, March 1, 2008; 45(2): 122 - 128.
[Abstract] [Full Text] [PDF]


Home page
J. Lipid Res.Home page
G. Catalano, E. Duchene, Z. Julia, W. Le Goff, E. Bruckert, M. J. Chapman, and M. Guerin
Cellular SR-BI and ABCA1-mediated cholesterol efflux are gender-specific in healthy subjects
J. Lipid Res., March 1, 2008; 49(3): 635 - 643.
[Abstract] [Full Text] [PDF]


Home page
J Am Coll CardiolHome page
W. A. van der Steeg, I. Holme, S. M. Boekholdt, M. L. Larsen, C. Lindahl, E. S.G. Stroes, M. J. Tikkanen, N. J. Wareham, O. Faergeman, A. G. Olsson, et al.
High-density lipoprotein cholesterol, high-density lipoprotein particle size, and apolipoprotein A-I: significance for cardiovascular risk: the IDEAL and EPIC-Norfolk studies.
J. Am. Coll. Cardiol., February 12, 2008; 51(6): 634 - 642.
[Abstract] [Full Text] [PDF]


Home page
J. Gerontol. A Biol. Sci. Med. Sci.Home page
J. F. P. Berbee, S. P. Mooijaart, A. J. M. de Craen, L. M. Havekes, D. van Heemst, P. C. N. Rensen, and R. G. J. Westendorp
Plasma Apolipoprotein CI Protects Against Mortality From Infection in Old Age
J. Gerontol. A Biol. Sci. Med. Sci., February 1, 2008; 63(2): 122 - 126.
[Abstract] [Full Text] [PDF]


Home page
J. Lipid Res.Home page
N.-P. Tang, L.-S. Wang, L. Yang, B. Zhou, H.-J. Gu, Q.-M. Sun, R.-H. Cong, H.-J. Zhu, and B. Wang
Protective effect of an endothelial lipase gene variant on coronary artery disease in a Chinese population
J. Lipid Res., February 1, 2008; 49(2): 369 - 375.
[Abstract] [Full Text] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
Y. Feng, F. Jacobs, E. Van Craeyveld, C. Brunaud, J. Snoeys, M. Tjwa, S. Van Linthout, and B. De Geest
Human ApoA-I Transfer Attenuates Transplant Arteriosclerosis via Enhanced Incorporation of Bone marrow-derived Endothelial Progenitor Cells
Arterioscler. Thromb. Vasc. Biol., February 1, 2008; 28(2): 278 - 283.
[Abstract] [Full Text] [PDF]


Home page
J Am Coll CardiolHome page
C. J. Lavie and R. V. Milani
Shedding light on high-density lipoprotein cholesterol: the post-ILLUMINATE era.
J. Am. Coll. Cardiol., January 1, 2008; 51(1): 56 - 58.
[Full Text] [PDF]


Home page
ANGIOLOGYHome page
P. Sritara, P. Patoomanunt, M. Woodward, K. Narksawat, S. Tulyadachanon, W. Ratanachaiwong, C. Sritara, F. Barzi, S. Yamwong, and S. Tanomsup
Associations Between Serum Lipids and Causes of Mortality in a Cohort of 3499 Urban Thais: The Electricity Generating Authority of Thailand (EGAT) Study
Angiology, January 1, 2008; 58(6): 757 - 763.
[Abstract] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
P. J. Barter and K.-A. Rye
Is There a Role for Fibrates in the Management of Dyslipidemia in the Metabolic Syndrome?
Arterioscler. Thromb. Vasc. Biol., January 1, 2008; 28(1): 39 - 46.
[Abstract] [Full Text] [PDF]


Home page
J. Lipid Res.Home page
Y. Ruixing, F. Qiming, Y. Dezhai, L. Shuquan, L. Weixiong, P. Shangling, W. Hai, Y. Yongzhong, H. Feng, and Q. Shuming
Comparison of demography, diet, lifestyle, and serum lipid levels between the Guangxi Bai Ku Yao and Han populations
J. Lipid Res., December 1, 2007; 48(12): 2673 - 2681.
[Abstract] [Full Text] [PDF]


Home page
NEJMHome page
P. J. Barter, M. Caulfield, M. Eriksson, S. M. Grundy, J. J.P. Kastelein, M. Komajda, J. Lopez-Sendon, L. Mosca, J.-C. Tardif, D. D. Waters, et al.
Effects of Torcetrapib in Patients at High Risk for Coronary Events
N. Engl. J. Med., November 22, 2007; 357(21): 2109 - 2122.
[Abstract] [Full Text] [PDF]


Home page
Am J Health Syst PharmHome page
S. W. Leonard, J. D. Joss, D. J. Mustacich, D. H. Blatt, Y. S. Lee, and M. G. Traber
Effects of vitamin E on cholesterol levels of hypercholesterolemic patients receiving statins
Am. J. Health Syst. Pharm., November 1, 2007; 64(21): 2257 - 2266.
[Abstract] [Full Text] [PDF]


Home page
NEJMHome page
P. Barter, A. M. Gotto, J. C. LaRosa, J. Maroni, M. Szarek, S. M. Grundy, J. J.P. Kastelein, V. Bittner, J.-C. Fruchart, and the Treating to New Targets Investigators
HDL Cholesterol, Very Low Levels of LDL Cholesterol, and Cardiovascular Events
N. Engl. J. Med., September 27, 2007; 357(13): 1301 - 1310.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Pathol.Home page
P J Twomey and D R Pledger
HDL-cholesterol and triglycerides: an overlooked issue?
J. Clin. Pathol., September 1, 2007; 60(9): 1065 - 1066.
[Full Text] [PDF]


Home page
J. Epidemiol. Community HealthHome page
O. Mytton, A. Gray, M. Rayner, and H. Rutter
Could targeted food taxes improve health?
J. Epidemiol. Community Health, August 1, 2007; 61(8): 689 - 694.
[Abstract] [Full Text] [PDF]


Home page
JAMAHome page
B. G. Nordestgaard, M. Benn, P. Schnohr, and A. Tybjaerg-Hansen
Nonfasting Triglycerides and Risk of Myocardial Infarction, Ischemic Heart Disease, and Death in Men and Women
JAMA, July 18, 2007; 298(3): 299 - 308.
[Abstract] [Full Text] [PDF]


Home page
J. Lipid Res.Home page
L. A. Morehouse, E. D. Sugarman, P.-A. Bourassa, T. M. Sand, F. Zimetti, F. Gao, G. H. Rothblat, and A. J. Milici
Inhibition of CETP activity by torcetrapib reduces susceptibility to diet-induced atherosclerosis in New Zealand White rabbits
J. Lipid Res., June 1, 2007; 48(6): 1263 - 1272.
[Abstract] [Full Text] [PDF]


Home page
J. Nutr.Home page
S. Baba, M. Natsume, A. Yasuda, Y. Nakamura, T. Tamura, N. Osakabe, M. Kanegae, and K. Kondo
Plasma LDL and HDL Cholesterol and Oxidized LDL Concentrations Are Altered in Normo- and Hypercholesterolemic Humans after Intake of Different Levels of Cocoa Powder
J. Nutr., June 1, 2007; 137(6): 1436 - 1441.
[Abstract] [Full Text] [PDF]


Home page
HeartHome page
J. M S Lee and R. P Choudhury
Prospects for atherosclerosis regression through increase in high-density lipoprotein and other emerging therapeutic targets
Heart, May 1, 2007; 93(5): 559 - 564.
[Abstract] [Full Text] [PDF]


Home page
NEJMHome page
J. J.P. Kastelein, S. I. van Leuven, L. Burgess, G. W. Evans, J. A. Kuivenhoven, P. J. Barter, J. H. Revkin, D. E. Grobbee, W. A. Riley, C. L. Shear, et al.
Effect of Torcetrapib on Carotid Atherosclerosis in Familial Hypercholesterolemia
N. Engl. J. Med., April 19, 2007; 356(16): 1620 - 1630.
[Abstract] [Full Text] [PDF]


Home page
NEJMHome page
S. E. Nissen, J.-C. Tardif, S. J. Nicholls, J. H. Revkin, C. L. Shear, W. T. Duggan, W. Ruzyllo, W. B. Bachinsky, G. P. Lasala, E. M. Tuzcu, et al.
Effect of Torcetrapib on the Progression of Coronary Atherosclerosis
N. Engl. J. Med., March 29, 2007; 356(13): 1304 - 1316.
[Abstract] [Full Text] [PDF]


Home page
Diabetes CareHome page
R. W. Grant and J. B. Meigs
Prevalence and Treatment of Low HDL Cholesterol Among Primary Care Patients With Type 2 Diabetes: An unmet challenge for cardiovascular risk reduction
Diabetes Care, March 1, 2007; 30(3): 479 - 484.
[Abstract] [Full Text] [PDF]


Home page
StrokeHome page
N. Sanossian, J. L. Saver, M. Navab, and B. Ovbiagele
High-Density Lipoprotein Cholesterol: An Emerging Target for Stroke Treatment
Stroke, March 1, 2007; 38(3): 1104 - 1109.
[Abstract] [Full Text] [PDF]


Home page
J Am Coll CardiolHome page
R. V. Milani and C. J. Lavie
Cholesteryl Ester Transfer Protein Inhibition: The Next Frontier in Combating Coronary Artery Disease?
J. Am. Coll. Cardiol., November 7, 2006; 48(9): 1791 - 1792.
[Full Text] [PDF]


Home page
J. Biol. Chem.Home page
C. W. Joyce, E. M. Wagner, F. Basso, M. J. Amar, L. A. Freeman, R. D. Shamburek, C. L. Knapper, J. Syed, J. Wu, B. L. Vaisman, et al.
ABCA1 Overexpression in the Liver of LDLr-KO Mice Leads to Accumulation of Pro-atherogenic Lipoproteins and Enhanced Atherosclerosis
J. Biol. Chem., November 3, 2006; 281(44): 33053 - 33065.
[Abstract] [Full Text] [PDF]


Home page
RadiologyHome page
W. S. Kerwin, K. D. O'Brien, M. S. Ferguson, N. Polissar, T. S. Hatsukami, and C. Yuan
Inflammation in Carotid Atherosclerotic Plaque: A Dynamic Contrast-enhanced MR Imaging Study
Radiology, November 1, 2006; 241(2): 459 - 468.
[Abstract] [Full Text] [PDF]


Home page
Eur Heart J SupplHome page
T. R. Pedersen
The gap between theory and practice: what do the trials tell us?
Eur. Heart J. Suppl., October 1, 2006; 8(suppl_F): F10 - F16.
[Abstract] [Full Text] [PDF]


Home page
Eur Heart J SupplHome page
E. Bruckert
Epidemiology of low HDL-cholesterol: results of studies and surveys
Eur. Heart J. Suppl., October 1, 2006; 8(suppl_F): F17 - F22.
[Abstract] [Full Text] [PDF]


Home page
Eur Heart J SupplHome page
H. Drexel
Reducing risk by raising HDL-cholesterol: the evidence
Eur. Heart J. Suppl., October 1, 2006; 8(suppl_F): F23 - F29.
[Abstract] [Full Text] [PDF]


Home page
GeneticsHome page
I. M. Stylianou, S.-W. Tsaih, K. DiPetrillo, N. Ishimori, R. Li, B. Paigen, and G. Churchill
Complex Genetic Architecture Revealed by Analysis of High-Density Lipoprotein Cholesterol in Chromosome Substitution Strains and F2 Crosses
Genetics, October 1, 2006; 174(2): 999 - 1007.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
P. J. Barter and K.-A. Rye
The Argument Against the Appropriateness of Over-the-Counter Statins
Circulation, September 19, 2006; 114(12): 1315 - 1320.
[Full Text] [PDF]


Home page
Eur Respir JHome page
A. Barcelo, F. Barbe, M. de la Pena, M. Vila, G. Perez, J. Pierola, J. Duran, and A. G. N. Agusti
Antioxidant status in patients with sleep apnoea and impact of continuous positive airway pressure treatment.
Eur. Respir. J., April 1, 2006; 27(4): 756 - 760.
[Abstract] [Full Text] [PDF]


Home page
Journal of Pharmacy PracticeHome page
J. M. Tovar and D. B. Schering
Management of Dyslipidemia in Special Populations
Journal of Pharmacy Practice, April 1, 2006; 19(2): 63 - 78.
[Abstract] [PDF]


Home page
J. Am. Coll. Nutr.Home page
Y. Ma, Y. Li, D. E. Chiriboga, B. C. Olendzki, J. R. Hebert, W. Li, K. Leung, A. R. Hafner, and I. S. Ockene
Association between Carbohydrate Intake and Serum Lipids.
J. Am. Coll. Nutr., April 1, 2006; 25(2): 155 - 163.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
P. J. Barter and K.-A. Rye
Cardioprotective Properties of Fibrates: Which Fibrate, Which Patients, What Mechanism?
Circulation, March 28, 2006; 113(12): 1553 - 1555.
[Full Text] [PDF]


Home page
J. Lipid Res.Home page
R. W. Clark, R. B. Ruggeri, D. Cunningham, and M. J. Bamberger
Description of the torcetrapib series of cholesteryl ester transfer protein inhibitors, including mechanism of action
J. Lipid Res., March 1, 2006; 47(3): 537 - 552.
[Abstract] [Full Text] [PDF]


Home page
J Am Coll CardiolHome page
P. J. Barter and J. J.P. Kastelein
Targeting Cholesteryl Ester Transfer Protein for the Prevention and Management of Cardiovascular Disease
J. Am. Coll. Cardiol., February 7, 2006; 47(3): 492 - 499.
[Abstract] [Full Text] [PDF]


Home page
J. Nutr.Home page
J. M. Arbones-Mainar, M. A. Navarro, S. Acin, M. A. Guzman, C. Arnal, J. C. Surra, R. Carnicer, H. M. Roche, and J. Osada
Trans-10, cis-12- and cis-9, trans-11-Conjugated Linoleic Acid Isomers Selectively Modify HDL-Apolipoprotein Composition in Apolipoprotein E Knockout Mice
J. Nutr., February 1, 2006; 136(2): 353 - 359.
[Abstract] [Full Text] [PDF]


Home page
Int J EpidemiolHome page
S. Kim and B. M Popkin
Commentary: Understanding the epidemiology of overweight and obesity--a real global public health concern
Int. J. Epidemiol., February 1, 2006; 35(1): 60 - 67.
[Full Text] [PDF]


Home page
QJMHome page
R. Ohashi, H. Mu, X. Wang, Q. Yao, and C. Chen
Reverse cholesterol transport and cholesterol efflux in atherosclerosis
QJM, December 1, 2005; 98(12): 845 - 856.
[Abstract] [Full Text] [PDF]


Home page
DiabetesHome page
R. de Vries, F. G. Perton, G. M. Dallinga-Thie, A. M. van Roon, B. H.R. Wolffenbuttel, A. van Tol, and R. P.F. Dullaart
Plasma Cholesteryl Ester Transfer Is a Determinant of Intima-Media Thickness in Type 2 Diabetic and Nondiabetic Subjects: Role of CETP and Triglycerides
Diabetes, December 1, 2005; 54(12): 3554 - 3559.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
T. Pischon, C. J. Girman, F. M. Sacks, N. Rifai, M. J. Stampfer, and E. B. Rimm
Non-High-Density Lipoprotein Cholesterol and Apolipoprotein B in the Prediction of Coronary Heart Disease in Men
Circulation, November 29, 2005; 112(22): 3375 - 3383.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
D.-Q. Peng, Z. Wu, G. Brubaker, L. Zheng, M. Settle, E. Gross, M. Kinter, S. L. Hazen, and J. D. Smith
Tyrosine Modification Is Not Required for Myeloperoxidase-induced Loss of Apolipoprotein A-I Functional Activities
J. Biol. Chem., October 7, 2005; 280(40): 33775 - 33784.
[Abstract] [Full Text] [PDF]


Home page
J. Lipid Res.Home page
J.-Y. Lee, J. M. Timmins, A. Mulya, T. L. Smith, Y. Zhu, E. M. Rubin, J. W. Chisholm, P. L. Colvin, and J. S. Parks
HDLs in apoA-I transgenic Abca1 knockout mice are remodeled normally in plasma but are hypercatabolized by the kidney
J. Lipid Res., October 1, 2005; 46(10): 2233 - 2245.
[Abstract] [Full Text] [PDF]


Home page
J. Lipid Res.Home page
B. F. Asztalos, M. de la Llera-Moya, G. E. Dallal, K. V. Horvath, E. J. Schaefer, and G. H. Rothblat
Differential effects of HDL subpopulations on cellular ABCA1- and SR-BI-mediated cholesterol efflux
J. Lipid Res., October 1, 2005; 46(10): 2246 - 2253.
[Abstract] [Full Text] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
V. Nambi and C. M. Ballantyne
Fat, Fit, and Leading the Charge: The Evolution of Measuring High-Density Lipoprotein Subpopulations
Arterioscler. Thromb. Vasc. Biol., October 1, 2005; 25(10): 2013 - 2015.
[Full Text] [PDF]


Home page
J. Nutr.Home page
J. Mukuddem-Petersen, W. Oosthuizen, and J. C. Jerling
A Systematic Review of the Effects of Nuts on Blood Lipid Profiles in Humans
J. Nutr., September 1, 2005; 135(9): 2082 - 2089.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
A. M. Vaughan and J. F. Oram
ABCG1 Redistributes Cell Cholesterol to Domains Removable by High Density Lipoprotein but Not by Lipid-depleted Apolipoproteins
J. Biol. Chem., August 26, 2005; 280(34): 30150 - 30157.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
H. Deguchi, N. M. Pecheniuk, D. J. Elias, P. M. Averell, and J. H. Griffin
High-Density Lipoprotein Deficiency and Dyslipoproteinemia Associated With Venous Thrombosis in Men
Circulation, August 9, 2005; 112(6): 893 - 899.
[Abstract] [Full Text] [PDF]


Home page
Diabetes CareHome page
R. B. Goldberg, D. M. Kendall, M. A. Deeg, J. B. Buse, A. J. Zagar, J. A. Pinaire, M. H. Tan, M. A. Khan, A. T. Perez, S. J. Jacober, et al.
A Comparison of Lipid and Glycemic Effects of Pioglitazone and Rosiglitazone in Patients With Type 2 Diabetes and Dyslipidemia
Diabetes Care, July 1, 2005; 28(7): 1547 - 1554.
[Abstract] [Full Text] [PDF]


Home page
Eur Heart J SupplHome page
G. Assmann
Calculating global risk: the key to intervention
Eur. Heart J. Suppl., July 1, 2005; 7(suppl_F): F9 - F14.
[Abstract] [Full Text] [PDF]


Home page
Eur Heart J SupplHome page
J. Shepherd
Raising HDL-cholesterol and lowering CHD risk: does intervention work?
Eur. Heart J. Suppl., July 1, 2005; 7(suppl_F): F15 - F22.
[Abstract] [Full Text] [PDF]


Home page
Eur Heart J SupplHome page
E. Bruckert, R. Pamphile, F. McCoy, and P. Andre
Defining the prevalence of low HDL-C in a European cohort of dyslipidaemic patients
Eur. Heart J. Suppl., July 1, 2005; 7(suppl_F): F23 - F26.
[Abstract] [Full Text] [PDF]